How do I know if I qualify for shorter HER2+ immunotherapy trials?
Community Member
5 days agoHello everyone I was diagnosed with HER2+ Invasive ductal carcinoma stage 1 In Nov 2025. Did 3 months of chemo weekly with immunotherapy Every 3 weeks. Had positive response to both.. Lympectomy 3 weeks ago. No active cancer cells left and some tumors completely gone just markers left. 🙏🏻 There is a trial for immunotherapy drug I’m on called. “short stop” which cut treatments down to 6,treatments vs 12 .. awaiting info to see if I get in. 🙏🏻 I had a 100% complete clinical response To my treatment which allows me to apply … fyi
Community Member
5 days agoWhat wonderful news about your complete clinical response! Trial eligibility often depends on specific medical criteria that your oncology team will evaluate based on your treatment history and current status. Since you've already applied for the shorter immunotherapy trial, your medical team is best positioned to determine if you meet all the requirements. Many others in this community have navigated similar decisions about clinical trials, so feel free to share any updates or questions as you learn more about your eligibility.
New to the community?
Create an account to connect with others navigating cancer.
Related Questions
- Understanding a Breast Cancer Diagnosis
- Seeking Options for Early-Stage Breast Cancer Treatment at 70+
- Advances in Treatment for Specific Breast Cancer Type?
- Should I take hormone therapy for DCIS at 69 with clear margins?
- Is anyone else diagnosed with HER2+ ER+ PR- metastatic breast cancer?
- Should I choose Kadcyla or Enhertu after residual HER2+ breast cancer?
- Are there clinical trials for cancer patients with pneumonitis?
- How do I know if I qualify for shorter HER2+ immunotherapy trials?
© 2026 Outcomes4Me Inc. All rights reserved.